Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition.

Frontiers in cellular and infection microbiology(2022)

引用 5|浏览14
暂无评分
摘要
These ZnO-Se NPs with synergetic anti-TB efficiency by combining the Mtb killing effects and host cell immunological inhibition effects were expected to serve as novel anti-TB agents for the development of more effective anti-TB strategy.
更多
查看译文
关键词
anti-TB agents,immunological inhibition,killing,macrophages,tuberculosis,zinc oxide-selenium nanoparticles
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要